Is autotaxin (ENPP2) the link between hepatitis C and hepatocellular cancer?

Amanda B. Cooper, Jianmin Wu, Debao Lu, Mary A. Maluccio

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

Hepatitis C is the most significant risk factor for development of hepatocellular carcinoma. Inflammation, fibrosis, and liver cell proliferation may contribute to cancer development either through malignant hepatocyte transformation or extracellular matrix remodeling within the tumor microenvironment. The study objective was to investigate differences in gene expression between patients with Hepatitis C (± cancer) and normal that might explain the increased cancer risk. Liver tissue was collected from three patient groups: 1) healthy patients, 2) Hepatitis C patients without cancer, 3) patients with Hepatitis C and hepatocellular carcinoma. Microarray analysis was performed on samples from each group. Western blot and real-time polymerase chain reaction (PCR) analyses corroborated the microarray data. A p value of 0.05 was set as significant. Microarray analysis showed overexpression of autotaxin in patients with cancer versus hepatitis patients or normal patients. Rho GTPase binding proteins (Cdc42s) associated with lysophosphatidic acid signaling were also overexpressed in cancer patients. Real-time polymerase chain reaction showed overexpression of several factors associated with autotaxin in patients with Hepatitis C (± cancer) versus normal patients. Patients with Hepatitis C and hepatocellular carcinoma show differential expression of various components of the autotaxin pathway versus normal patients. This merits further investigation in the context of early diagnosis.

Original languageEnglish (US)
Pages (from-to)1628-1635
Number of pages8
JournalJournal of Gastrointestinal Surgery
Volume11
Issue number12
DOIs
StatePublished - Dec 1 2007

Fingerprint

Liver Neoplasms
Hepatitis C
Microarray Analysis
Neoplasms
Hepatocellular Carcinoma
Real-Time Polymerase Chain Reaction
rho GTP-Binding Proteins
Tumor Microenvironment
Liver Cirrhosis
Hepatitis
Extracellular Matrix
Early Diagnosis
Hepatocytes
Carrier Proteins
Western Blotting
Cell Proliferation

All Science Journal Classification (ASJC) codes

  • Surgery
  • Gastroenterology

Cite this

Cooper, Amanda B. ; Wu, Jianmin ; Lu, Debao ; Maluccio, Mary A. / Is autotaxin (ENPP2) the link between hepatitis C and hepatocellular cancer?. In: Journal of Gastrointestinal Surgery. 2007 ; Vol. 11, No. 12. pp. 1628-1635.
@article{fe7d126106904934b77f6ffa729783d1,
title = "Is autotaxin (ENPP2) the link between hepatitis C and hepatocellular cancer?",
abstract = "Hepatitis C is the most significant risk factor for development of hepatocellular carcinoma. Inflammation, fibrosis, and liver cell proliferation may contribute to cancer development either through malignant hepatocyte transformation or extracellular matrix remodeling within the tumor microenvironment. The study objective was to investigate differences in gene expression between patients with Hepatitis C (± cancer) and normal that might explain the increased cancer risk. Liver tissue was collected from three patient groups: 1) healthy patients, 2) Hepatitis C patients without cancer, 3) patients with Hepatitis C and hepatocellular carcinoma. Microarray analysis was performed on samples from each group. Western blot and real-time polymerase chain reaction (PCR) analyses corroborated the microarray data. A p value of 0.05 was set as significant. Microarray analysis showed overexpression of autotaxin in patients with cancer versus hepatitis patients or normal patients. Rho GTPase binding proteins (Cdc42s) associated with lysophosphatidic acid signaling were also overexpressed in cancer patients. Real-time polymerase chain reaction showed overexpression of several factors associated with autotaxin in patients with Hepatitis C (± cancer) versus normal patients. Patients with Hepatitis C and hepatocellular carcinoma show differential expression of various components of the autotaxin pathway versus normal patients. This merits further investigation in the context of early diagnosis.",
author = "Cooper, {Amanda B.} and Jianmin Wu and Debao Lu and Maluccio, {Mary A.}",
year = "2007",
month = "12",
day = "1",
doi = "10.1007/s11605-007-0322-9",
language = "English (US)",
volume = "11",
pages = "1628--1635",
journal = "Journal of Gastrointestinal Surgery",
issn = "1091-255X",
publisher = "Springer New York",
number = "12",

}

Is autotaxin (ENPP2) the link between hepatitis C and hepatocellular cancer? / Cooper, Amanda B.; Wu, Jianmin; Lu, Debao; Maluccio, Mary A.

In: Journal of Gastrointestinal Surgery, Vol. 11, No. 12, 01.12.2007, p. 1628-1635.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Is autotaxin (ENPP2) the link between hepatitis C and hepatocellular cancer?

AU - Cooper, Amanda B.

AU - Wu, Jianmin

AU - Lu, Debao

AU - Maluccio, Mary A.

PY - 2007/12/1

Y1 - 2007/12/1

N2 - Hepatitis C is the most significant risk factor for development of hepatocellular carcinoma. Inflammation, fibrosis, and liver cell proliferation may contribute to cancer development either through malignant hepatocyte transformation or extracellular matrix remodeling within the tumor microenvironment. The study objective was to investigate differences in gene expression between patients with Hepatitis C (± cancer) and normal that might explain the increased cancer risk. Liver tissue was collected from three patient groups: 1) healthy patients, 2) Hepatitis C patients without cancer, 3) patients with Hepatitis C and hepatocellular carcinoma. Microarray analysis was performed on samples from each group. Western blot and real-time polymerase chain reaction (PCR) analyses corroborated the microarray data. A p value of 0.05 was set as significant. Microarray analysis showed overexpression of autotaxin in patients with cancer versus hepatitis patients or normal patients. Rho GTPase binding proteins (Cdc42s) associated with lysophosphatidic acid signaling were also overexpressed in cancer patients. Real-time polymerase chain reaction showed overexpression of several factors associated with autotaxin in patients with Hepatitis C (± cancer) versus normal patients. Patients with Hepatitis C and hepatocellular carcinoma show differential expression of various components of the autotaxin pathway versus normal patients. This merits further investigation in the context of early diagnosis.

AB - Hepatitis C is the most significant risk factor for development of hepatocellular carcinoma. Inflammation, fibrosis, and liver cell proliferation may contribute to cancer development either through malignant hepatocyte transformation or extracellular matrix remodeling within the tumor microenvironment. The study objective was to investigate differences in gene expression between patients with Hepatitis C (± cancer) and normal that might explain the increased cancer risk. Liver tissue was collected from three patient groups: 1) healthy patients, 2) Hepatitis C patients without cancer, 3) patients with Hepatitis C and hepatocellular carcinoma. Microarray analysis was performed on samples from each group. Western blot and real-time polymerase chain reaction (PCR) analyses corroborated the microarray data. A p value of 0.05 was set as significant. Microarray analysis showed overexpression of autotaxin in patients with cancer versus hepatitis patients or normal patients. Rho GTPase binding proteins (Cdc42s) associated with lysophosphatidic acid signaling were also overexpressed in cancer patients. Real-time polymerase chain reaction showed overexpression of several factors associated with autotaxin in patients with Hepatitis C (± cancer) versus normal patients. Patients with Hepatitis C and hepatocellular carcinoma show differential expression of various components of the autotaxin pathway versus normal patients. This merits further investigation in the context of early diagnosis.

UR - http://www.scopus.com/inward/record.url?scp=36148970470&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=36148970470&partnerID=8YFLogxK

U2 - 10.1007/s11605-007-0322-9

DO - 10.1007/s11605-007-0322-9

M3 - Article

C2 - 17902023

AN - SCOPUS:36148970470

VL - 11

SP - 1628

EP - 1635

JO - Journal of Gastrointestinal Surgery

JF - Journal of Gastrointestinal Surgery

SN - 1091-255X

IS - 12

ER -